Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism
Granger, C.B.; Armaganijan, L.V.
Circulation 125(1): 159-64; Discussion 164
2012
ISSN/ISBN: 0009-7322 PMID: 22215890 DOI: 10.1161/circulationaha.111.031146
Accession: 054618980
PDF emailed within 0-6 h: $19.90
Related References
Ansell, J. 2012: New oral anticoagulants should not be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation Circulation 125(1): 165-70; Discussion 170Bentz, B.A. 2015: Nonvitamin K antagonist oral anticoagulants in everyday practice: Stroke prevention in atrial fibrillation and treatment of venous thromboembolism Journal of the American Association of Nurse Practitioners 27(12): 721-731
Hong, K.-S. 2019: Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation Journal of Stroke 21(3): 259-275
Olesen, J.B.; Fauchier, L.; Lane, D.A.; Taillandier, S.; Lip, G.Y.H. 2012: Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project Chest 141(1): 147-153
Agarwal, M.B.; Verma, S.; Mahapatra, M.; Tripathi, A.K.; Bhave, A.; Deshpande, A.; Vora, A.; Dalal, J.J.; Shah, A.B.; Bichu, S. 2012: Balancing efficacy and bleeding risk in the prevention of stroke due to atrial fibrillation with newer oral anticoagulants Indian Journal of Hematology and Blood Transfusion: An Official Journal of Indian Society of Hematology and Blood Transfusion 28(3): 129-143
Huang, Y.-L.; Chen, C.-Y.; Chu, C.-C. 2022: Risk of major bleeding and thromboembolism in Asian patients with nonvalvular atrial fibrillation using direct oral anticoagulants versus warfarin International Journal of Clinical Pharmacy 44(1): 34-43
Verheugt, F.W.A. 2013: Advances in stroke prevention in atrial fibrillation: enhanced risk stratification combined with the newer oral anticoagulants Clinical Cardiology 36(6): 312-322
Hughes, M.; Lip, G.Y.H. 2008: Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data Thrombosis and Haemostasis 99(2): 295-304
Zhu, J.; Yang, Y. 2014: New oral anticoagulants and thromboembolism prevention in atrial fibrillation Zhonghua Xin Xue Guan Bing Za Zhi 42(5): 370-371
Liu, X-Hua.; Gao, X-Fei.; Chen, C-Feng.; Chen, B.; Xu, Y-Zhou. 2020: Thromboembolism and bleeding risk in atrial fibrillation ablation with uninterrupted anticoagulation between new oral anticoagulants and vitamin K antagonists: insights from an updated meta-analysis Journal of Thrombosis and Thrombolysis 50(1): 201-210
Hughes, M.; Lip, G.Y.H.; G D, E.S. M. 2008: Stroke and thromboembolism in atrial fibrillation : A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data : New Horizons in Vascular Biology and Thrombosis Society of Thrombosis and Haemostasis Research 99(2): 295-304
Zeus, T.; Kelm, M.; Bode, C. 2015: Prophylaxis of thromboembolism in atrial fibrillation: new oral anticoagulants and left atrial appendage closure Deutsche Medizinische Wochenschrift 140(16): 1213-1215
Lang, N.N.; Connelly, D.T. 2013: Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation Journal of the Royal College of Physicians of Edinburgh 43(2): 151-158
Sharma, M.; Cornelius, V.R.; Patel, J.P.; Davies, J.Graham.; Molokhia, M. 2015: Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis Circulation 132(3): 194-204
Hajhosseiny, R.; Sabir, I.; Lip, G.Y.H. 2014: Non-vitamin K antagonist oral anticoagulants in atrial fibrillation and venous thromboembolism: where are we now? Hospital Practice 42(4): 153-162
Becattini, C.; Vedovati, M.Cristina.; Agnelli, G. 2012: Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature Thrombosis Research 129(3): 392-400
Colonna, P. 2012: New oral anticoagulants for the prevention of thromboembolism in atrial fibrillation: from clinical evidence to appropriate use Giornale Italiano di Cardiologia 13(11 Suppl. 1): 3s
Li, J.; Guo, Y.-t.; Wang, C.-j. 2013: Clinical features and risk factors of stroke/thromboembolism and bleeding in the elderly patients with atrial fibrillation Zhonghua Xin Xue Guan Bing Za Zhi 41(11): 927-930
Chen, N.; Gabriel, N.; Brooks, M.M.; Hernandez, I. 2021: Joint Latent Class Analysis of Oral Anticoagulation use and Risk of Stroke or Systemic Thromboembolism in Patients with Atrial Fibrillation American Journal of Cardiovascular Drugs: Drugs Devices and other Interventions 21(5): 573-580
Philippart, R.; Brunet-Bernard, A.; Clementy, N.; Bourguignon, T.; Mirza, A.; Angoulvant, D.; Babuty, D.; Lip, G.Y.H.; Fauchier, L. 2016: Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis. the Loire Valley Atrial Fibrillation Project Thrombosis and Haemostasis 115(5): 1056-1063